Intravenous solutions are used as vehicles for nutrition and hydration support for patients who are unable to have oral intake. They reduce risk of infections and are preferred over oral medication in critical care situations. The global Intravenous Solutions Market is estimated to be valued at US$665.66 billion in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving growth in the intravenous solutions market is the rising investments in healthcare infrastructure across the globe. Governments in various countries are investing heavily to modernize and expand healthcare facilities to improve access and quality of care. This is increasing the adoption of advanced medical delivery systems such as intravenous therapy. For instance, according to the World Bank, global healthcare spending reached US$ 7.8 trillion in 2020, up from US$ 7.6 trillion in 2019. Such increasing investments are positively impacting the demand for intravenous solutions from hospitals and clinics worldwide. Additionally, private equity firms are also investing in healthcare infrastructure projects, thereby facilitating market growth over the forecast period.
Segment Analysis
The Global Intravenous Solutions Market Size is dominated by crystalloids sub segment as crystalloids such as normal saline are the most widely used fluids for parenteral hydration and correcting electrolyte imbalances in patients. Crystalloid solutions account for over 75% of the total market share owing to their wide range of applications, low cost compared to other intravenous therapies, and no significant side effects if administered properly.
Key Takeaways
The global intravenous solutions market is expected to witness high growth during the forecast period of 2024 to 2031.
North America currently dominates the intravenous solutions market, accounting for over 40% of the global market share in 2024. This is attributed to factors such as increasing number of surgeries, rising geriatric population prone to chronic diseases and well-established healthcare infrastructure in the region.
Key players operating in the intravenous solutions market are Amcor plc, Bemis Company Inc. (acquired by Amcor), Sonoco Products Company, Sealed Air Corporation, DS Smith Plc. Amcor plc is expected to continue dominating the market with over 20% revenue share owing to its wide product portfolio and strong global distribution network across 100 countries.
Get More Insights On This Topic: https://www.newsstatix.com/intravenous-solutions-market-size-share-analysis-2023-2030/
Comments
0 comment